Galderma Group Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Galderma Group Ltd
Galderma was formed in 1981 as a joint venture between Nestle and L’Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma’s science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs around 7,00 people.
/ 
Frequently asked questions
To buy Galderma Group Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Galderma Group Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Galderma Group Ltd is GALD:xswx. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Galderma Group Ltd has its primary listing on SIX Swiss Exchange. You can trade Galderma Group Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Galderma Group Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Galderma Group Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Galderma Group Ltd.